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Infusion pumps are sophisticated, safety critical devices that are used by people with a range of skills 
and backgrounds. Errors with various degrees of severity have been reported in their use, e.g. (ISMP, 
2007), and they have been implicated in many medication errors (e.g. Husch et al, 2005). These 
incidents are typically not due to device failures, but to pumps being used in ways that were not 
anticipated by their developers. An example would be the avoidance of, or need to work around, Dose 
Error Reduction Systems (DERS) on IV infusion pumps. Such systems are designed to protect patients 
and users by limiting the potential for inadvertent, incorrect programing (Sims et al, 2010), but may not 
take into account specifics regarding the context in which they are being used (AAMI/FDA, 2010). 
One of the challenges in developing infusion pumps that are fit for purpose is that they are used 
pervasively across many branches of healthcare for delivery of various treatments to people with many 
different conditions (Iacovides, Cox & Blandford, 2013). If intravenous medication and other 
procedures involving infusion devices are to become safer then there needs to be convergence between 
the ways they are intended to be used and the ways they are actually used in practice. This is a concern 
for all involved in the development, regulation, procurement, training and use of infusion devices.  
Many factors influence the design of next-generation devices, including regulation and standards, and 
procurement policies and practices. In turn, the design of devices, local policies about use and the ways 
in which staff are trained influence performance. In principle, there should be a virtuous circle in which 
an understanding of actual use informs future regulation, procurement, design, policy, etc. However, 
this can be difficult to achieve in practice. Real performance is currently often invisible, and reports 
where actual use deviates from intended use tend to be dismissed as anecdotes, deviant behaviour, “off-
label use”, violations, etc. Post-market surveillance typically focuses on reported incidents and major 
problems. It is difficult for a rich understanding of real performance to feed back and influence 
regulation and procurement. 
Without a complete loop in which understanding of actual use feeds into design, we end up with pumps 
that are not fit for purpose and whose safety is therefore compromised. The potential for a virtuous 
circle is missed because the feedback loop is broken. The aim of this paper is to “make visible”, and 
give a voice to, some of the less prominent, but nevertheless important, activities that exemplify real 
practices that result from the design, policy and training decisions that precede them. We do this by 
summarizing issues that we have identified across a number of studies of infusion pump use and 
training and, where possible, the factors that shape behaviours. 
Our paper includes examples from both published papers and work-in-progress, that describe nurse 
training, critical care, oncology, hematology, emergency room, surgery and medication administration 
record design (e.g., Rajkomar & Blandford, 2012; Furniss, Blandford & Mayer, 2011; Back & Cox, 
2013). These examples of real practice cover only a small part of the space of all practices. But by 
“making visible” these practices, we move a step closer to being able to reason about implications for 
design, not just for devices but also for surrounding systems (prescribing, training, procurement, 
regulation, etc.), as well as implications for use (e.g. standardizing best practice within particular 
contexts).  
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